» Articles » PMID: 37014126

Glycosphingolipids Within Membrane Contact Sites Influence Their Function As Signaling Hubs in Neurodegenerative Diseases

Overview
Journal FEBS Open Bio
Specialty Biology
Date 2023 Apr 4
PMID 37014126
Authors
Affiliations
Soon will be listed here.
Abstract

Intracellular organelles carry out many of their functions by engaging in extensive interorganellar communication through specialized membrane contact sites (MCSs) formed where two organelles tether to each other or to the plasma membrane (PM) without fusing. In recent years, these ubiquitous membrane structures have emerged as central signaling hubs that control a multitude of cellular pathways, ranging from lipid metabolism/transport to the exchange of metabolites and ions (i.e., Ca ), and general organellar biogenesis. The functional crosstalk between juxtaposed membranes at MCSs relies on a defined composite of proteins and lipids that populate these microdomains in a dynamic fashion. This is particularly important in the nervous system, where alterations in the composition of MCSs have been shown to affect their functions and have been implicated in the pathogenesis of neurodegenerative diseases. In this review, we focus on the MCSs that are formed by the tethering of the endoplasmic reticulum (ER) to the mitochondria, the ER to the endo-lysosomes and the mitochondria to the lysosomes. We highlight how glycosphingolipids that are aberrantly processed/degraded and accumulate ectopically in intracellular membranes and the PM change the topology of MCSs, disrupting signaling pathways that lead to neuronal demise and neurodegeneration. In particular, we focus on neurodegenerative lysosomal storage diseases linked to altered glycosphingolipid catabolism.

Citing Articles

Linking glycosphingolipid metabolism to disease-related changes in the plasma membrane proteome.

Monkhouse H, Deane J Biochem Soc Trans. 2024; 52(6):2477-2486.

PMID: 39641585 PMC: 11668283. DOI: 10.1042/BST20240315.


Altered GM1 catabolism affects NMDAR-mediated Ca signaling at ER-PM junctions and increases synaptic spine formation in a GM1-gangliosidosis model.

Weesner J, Annunziata I, van de Vlekkert D, Robinson C, Campos Y, Mishra A Cell Rep. 2024; 43(5):114117.

PMID: 38630590 PMC: 11244331. DOI: 10.1016/j.celrep.2024.114117.


Sphingolipids in mitochondria-from function to disease.

Jamil M, Cowart L Front Cell Dev Biol. 2023; 11:1302472.

PMID: 38078003 PMC: 10702779. DOI: 10.3389/fcell.2023.1302472.


Metabolic Markers and Association of Biological Sex in Lupus Nephritis.

Wolf B, Blaschke C, Mungaray S, Weselman B, Stefanenko M, Fedoriuk M Int J Mol Sci. 2023; 24(22).

PMID: 38003679 PMC: 10671813. DOI: 10.3390/ijms242216490.


An open chat with… Sandro Sonnino.

Tsagakis I, Sonnino S FEBS Open Bio. 2023; 13(9):1544-1547.

PMID: 37589211 PMC: 10476558. DOI: 10.1002/2211-5463.13689.

References
1.
Boutry M, Kim P . ORP1L mediated PI(4)P signaling at ER-lysosome-mitochondrion three-way contact contributes to mitochondrial division. Nat Commun. 2021; 12(1):5354. PMC: 8429648. DOI: 10.1038/s41467-021-25621-4. View

2.
Westermann B . The mitochondria-plasma membrane contact site. Curr Opin Cell Biol. 2015; 35:1-6. DOI: 10.1016/j.ceb.2015.03.001. View

3.
Ballabio A, Bonifacino J . Lysosomes as dynamic regulators of cell and organismal homeostasis. Nat Rev Mol Cell Biol. 2019; 21(2):101-118. DOI: 10.1038/s41580-019-0185-4. View

4.
Fog C, Kirkegaard T . Animal models for Niemann-Pick type C: implications for drug discovery & development. Expert Opin Drug Discov. 2019; 14(5):499-509. DOI: 10.1080/17460441.2019.1588882. View

5.
Cisneros J, Belton T, Shum G, Molakal C, Wong Y . Mitochondria-lysosome contact site dynamics and misregulation in neurodegenerative diseases. Trends Neurosci. 2022; 45(4):312-322. PMC: 8930467. DOI: 10.1016/j.tins.2022.01.005. View